Alopecia World
www.alopeciaworld.com
Pfizer PF 06651600- Breakthrough Technology Jak 3
phase 2 release of data expected sept 15, Pfizer will start phase 3 in 2019.
Replies to This Discussion
-
Permalink Reply by Nor75 on
-
Kevin, we talk about one JAK which will not be continued for AA because two people had side effects in the trial:PF 06700841
the other one PF 06651600 will continue, but I am concerned that they might take that away as well if something happens in phase III.
if that happens and Concert looses the patent, then we end up with ATI 501 only.
but we can do something to avoid this: talk to our national support groups and get the message out that it is not “just cosmetic”
-
-
so why they will do clinical phase trials that it inhibits Jack specifically for Arata alopecia for ultimately all stopped. anyway I have access to xeljanz so I speak on behalf of all those who do not have access.
-
-
Seems a bit more hopeful https://www.belgraviacentre.com/blog/2018-timeline-update-for-ctp-5...
-
-
Singh do not listen to any of these articles does not confirm what he says
-
-
Singh I was at my bank to do the transfer then bank and I received my order after two or three weeks
on the other hand I have not yet taken the drugs I have to test them in the laboratory and I do not promise you that you can receive the drugs because badly at the customs me they let me pass. Im french - Attachments:
-
-
And I do not “talk shit” ... lower your voice and words here.
And yes, I have Xeljanz at home for 12 months. That is not a problem in Europe. Will I ever use it? Hopefully not...
There is an exposure for us and together as a community we can do something about it.
Again: They had TWO medications tested, and they continue with ONE.
Reason: Two participants (only) had resolvable side effects
-
-
these are minimal side effects otherwise they will even start phase 3, and maybe you have xeljanz but can not have it
-
-
Man, I really think you are suffering from a few serious misapprehensions
-
-
http://www.evaluate.com/vantage/articles/analysis/tyk2-reaches-tipp...
quote
So it was surprising to see the company ditch PF-06700841 in alopecia in favour of its Jak3 inhibitor, PF-06651600 – despite the Tyk/Jak1 inhibitor showing a 49.5-point reduction in the severity of alopecia tool (SALT) versus the Jak3 inhibitor’s 33.6-point reduction.
unquote
http://www.evaluate.com/vantage/articles/events/upcoming-events/upc...
-
-
Hi Nor75,
Thabks for all the information it is unsettling if they try not bringing any of these drugs to market ! Can I ask what does salt score mean? The higher the better ?
Why would you not use xeljanz ??
I am going to write to Alopecia uk and asked if they will or organise a campaign to make sure consultatants and other specialists break out from calling alopecia cosmetic !
© 2024 Created by Alopecia World.
Powered by
